Alves C. Silva

Villejuif, 94800, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.

Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.

Journal: Research square

Published: November 24, 2025

The interplay between gut microbiota, antibiotics, and immune checkpoint inhibitors in patients with cancer: A narrative review with biological and clinical aspects.

The interplay between gut microbiota, antibiotics, and immune checkpoint inhibitors in patients with cancer: A narrative review with biological and clinical aspects.

Journal: Critical reviews in oncology/hematology

Published: April 05, 2025

Optimizing muscle mass and function in advanced lung cancer patients: randomized, double-blind, placebo-controlled trial protocol using High Eicosapentaenoic acid and PROtein (HEPRO) to modulate epigenetics, reduce toxicity and improve gut microbiota.

Optimizing muscle mass and function in advanced lung cancer patients: randomized, double-blind, placebo-controlled trial protocol using High Eicosapentaenoic acid and PROtein (HEPRO) to modulate epigenetics, reduce toxicity and improve gut microbiota.

Journal: PeerJ

Published: November 21, 2024

Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS).

Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS).

Journal: Nature communications

Published: October 18, 2024

Gut Microbiota-Related Biomarkers in Immuno-Oncology.

Gut Microbiota-Related Biomarkers in Immuno-Oncology.

Journal: Annual review of pharmacology and toxicology

Published: September 11, 2024

Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome.

Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome.

Journal: Cell

Published: August 30, 2023

Circulating acetylated polyamines correlate with Covid-19 severity in cancer patients.

Circulating acetylated polyamines correlate with Covid-19 severity in cancer patients.

Journal: Aging

Published: July 13, 2021

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.

Journal: Cell death and differentiation

Published: January 30, 2021

Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer.

Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer.

Journal: Nature medicine

Published: December 15, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026